Bio-Techne (TECH) Shares Outstanding (2009 - 2026)
Bio-Techne's (TECH) quarterly Shares Outstanding (Entity) came in at $156.5 million in Q1 2026, little changed year-on-year from $156.8 million in Q1 2025, and little changed quarter-over-quarter from $155.9 million in Q4 2025.
Bio-Techne (TECH) Shares Outstanding (2009 - 2026) Analysis & Trends
Bio-Techne's Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $156.5 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.16% year-over-year to $156.5 million in Q1 2026; TTM through Mar 2026 was $156.5 million, a 0.16% change from a year earlier, with the FY2025 full-year figure at $155.0 million, down 2.05% from the prior year.
- Shares Outstanding (Entity) was little changed at $156.5 million in Q1 2026 per TECH's latest filing, from $155.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $158.9 million in Q3 2024 and bottomed at $155.0 million in Q2 2025.
- The 5-year median for Shares Outstanding (Entity) is $157.1 million (2022), against an average of $157.1 million.
- Across the five-year window, Shares Outstanding (Entity) grew 1.05% in 2022 and fell 2.05% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $157.1 million in 2022, then rose by 0.03% to $157.1 million in 2023, then advanced by 0.49% to $157.9 million in 2024, then dropped by 1.29% to $155.9 million in 2025, then grew by 0.41% to $156.5 million in 2026.
- Per Business Quant, the three latest TECH Shares Outstanding (Entity) figures stand at $156.5 million (Q1 2026), $155.9 million (Q4 2025), and $155.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Bio-Techne | 11.19 Bn | 10.98 Bn | 208.29 Mn | 156.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.33 Mn |
| Dec 31, 2025 | 155.84 Mn |
| Sep 30, 2025 | 155.46 Mn |
| Jun 30, 2025 | 157.52 Mn |
| Mar 31, 2025 | 157.37 Mn |
| Dec 31, 2024 | 158.43 Mn |
| Sep 30, 2024 | 158.53 Mn |
| Jun 30, 2024 | 157.71 Mn |
| Mar 31, 2024 | 157.31 Mn |
| Dec 31, 2023 | 157.53 Mn |
| Sep 30, 2023 | 158.13 Mn |
| Jun 30, 2023 | 157.18 Mn |
| Mar 31, 2023 | 157.31 Mn |
| Dec 31, 2022 | 157.01 Mn |
| Sep 30, 2022 | 156.93 Mn |
| Jun 30, 2022 | 156.88 Mn |
| Mar 31, 2022 | 157.09 Mn |
| Dec 31, 2021 | 157.24 Mn |
| Sep 30, 2021 | 156.38 Mn |
| Jun 30, 2021 | 154.99 Mn |